Current and emerging methods of antibiotic susceptibility testing
ZA Khan, MF Siddiqui, S Park - Diagnostics, 2019 - mdpi.com
Antibiotic susceptibility testing (AST) specifies effective antibiotic dosage and formulates a
profile of empirical therapy for the proper management of an individual patient's health …
profile of empirical therapy for the proper management of an individual patient's health …
Prevalence and characterization of beta-lactamase-producing Escherichia coli isolates from a tertiary care hospital in India
BACKGROUND: The purpose of the study was to determine the prevalence and
characterize the resistance profiles of Escherichia coli isolated from various clinical …
characterize the resistance profiles of Escherichia coli isolated from various clinical …
First Detection of Extensively Drug-Resistant Salmonella Typhi Isolates Harboring VIM and GES Genes for Carbapenem Resistance from Faisalabad, Pakistan
Rapid emergence of resistance in Salmonella enterica serovar Typhi (Salmonella Typhi)
against most of the available therapeutic options for typhoid has rendered its treatment more …
against most of the available therapeutic options for typhoid has rendered its treatment more …
Geographical Distribution of β-Lactam Resistance among Klebsiella spp. from Selected Health Facilities in Ghana
E Quansah, P Amoah Barnie… - Tropical Medicine and …, 2019 - mdpi.com
β-Lactam-resistant Klebsiella isolates continue to cause multidrug resistance infections
worldwide. This study aimed to describe the geographical distribution of extended spectrum …
worldwide. This study aimed to describe the geographical distribution of extended spectrum …
Possible step-up in prevalence for Escherichia coli ST131 from fecal to clinical isolates: inferred virulence potential comparative studies within phylogenetic group B2
T Kudinha, F Kong - Journal of Biomedical Science, 2022 - Springer
Background Escherichia coli sequence type (ST) 131 is an important urinary tract pathogen,
and is responsible for considerable healthcare-associated problems and costs worldwide. A …
and is responsible for considerable healthcare-associated problems and costs worldwide. A …
Occurrence of Multidrug-Resistant (MDR) Extended-Spectrum Beta-lactamase (ESBL)-Producing Escherichia coli in Wastewater and Natural Water Sources from the …
K Satyaprakash, PK Pesingi, A Das, MR Vineeth… - Water, Air, & Soil …, 2024 - Springer
The present study assessed the presence of ESBL-producing Escherichia coli in livestock
farm wastewater (LFWW), hospital wastewater (HWW), and natural water sources (NWS) …
farm wastewater (LFWW), hospital wastewater (HWW), and natural water sources (NWS) …
In-silico insights of ESBL variants and tracking the probable sources of ESBL-producing Escherichia coli in a small-scale poultry farm
L Sharmila, A Pal, R Biswas, K Batabyal, S Dey… - Microbial …, 2024 - Elsevier
Commercial broiler farms faces challenges of extended spectrum beta-lactamase (ESBL)-
producing Escherichia coli transmitted from both vertical and horizontal routes …
producing Escherichia coli transmitted from both vertical and horizontal routes …
Clinical Outcomes of Third-Generation Cephalosporin Definitive Therapy for Bloodstream Infections Due to Enterobacterales with Potential AmpC Induction: A Single …
G Vossius, C Meex, F Moerman, M Thys, M Ernst… - Pathogens, 2023 - mdpi.com
The recommended therapy for severe infections caused by AmpC-inducible
Enterobacterales (AmpC-E) typically involves cefepime or carbapenems. In an era of …
Enterobacterales (AmpC-E) typically involves cefepime or carbapenems. In an era of …
Sub‐acute toxicological and behavioural effects of two candidate therapeutics, cinnamaldehyde and eugenol, for treatment of ESBL producing‐quinolone resistant …
L Dhara, A Tripathi - Clinical and Experimental Pharmacology …, 2020 - Wiley Online Library
Present study deals with evaluation of antibacterial activity of cinnamaldehyde and eugenol
against both extended‐spectrum‐β‐lactamase (ESBL)‐producing and quinolone resistant …
against both extended‐spectrum‐β‐lactamase (ESBL)‐producing and quinolone resistant …
[HTML][HTML] Antibiotic Resistance Pattern and Prevalence of Virulence Factors among ESBLs-producing Escherichia coli Causing Urinary Tract Infections
S Kazemi, A Mojtahedi, F Hosseini - Iranian Journal of Medical Microbiology, 2023 - ijmm.ir
Background & Aim: Urinary tract infections (UTIs) pose a significant global health threat,
primarily attributed to bacteria producing extended-spectrum beta-lactamases (ESBLs), with …
primarily attributed to bacteria producing extended-spectrum beta-lactamases (ESBLs), with …